# Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli

Study · id `cardio:ct-nct07794306` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07794306](<https://clinicaltrials.gov/study/NCT07794306>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07794306

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 510 participants.

## Technical summary

Registry record NCT07794306. Randomized; single masking; primary purpose treatment. Start 2026-10-26 (anticipated); primary completion 2028-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 510 participants (planned count; ClinicalTrials.gov record NCT07794306, source copy `cardio:ctgov-nct07794306-2026-08-31`, retrieved 2026-10-26)
- Planned start: 2026-10-26 (anticipated) (ClinicalTrials.gov record NCT07794306, source copy `cardio:ctgov-nct07794306-2026-08-31`, retrieved 2026-10-26)
- Primary completion: 2028-07-31 (anticipated) (ClinicalTrials.gov record NCT07794306, source copy `cardio:ctgov-nct07794306-2026-08-31`, retrieved 2026-10-26)
- Completion: 2033-12-31 (anticipated) (ClinicalTrials.gov record NCT07794306, source copy `cardio:ctgov-nct07794306-2026-08-31`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT07794306, source copy `cardio:ctgov-nct07794306-2026-08-31`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07794306-2026-08-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli
- Acronym: BALANCE
- Condition: Aortic Valve Stenosis
- Intervention (Device): Meril Octapro+ THV System
- Intervention (Device): Abbott Navitor/Navitor Vision THV system
- Lead sponsor: Universitätsklinikum Hamburg-Eppendorf
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Universitätsklinikum Hamburg-Eppendorf (`cardio:org-universitatsklinikum-hamburg-eppendorf`)

## Provenance

Content hash: fda323755e1e794f65f60e215e3db16129338463f91a99f3d0a50252bbd1ec3f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
